Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520262-17-000020
Filing Date
2017-04-27
Accepted
2017-04-27 09:01:12
Documents
67
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20170331x10q.htm 10-Q 1760697
2 EX-10.1 alks-20170331ex1013bb0ab.htm EX-10.1 164551
3 EX-10.2 alks-20170331ex102cd12a7.htm EX-10.2 149490
4 EX-31.1 alks-20170331ex31168cdc8.htm EX-31.1 47474
5 EX-31.2 alks-20170331ex31239f031.htm EX-31.2 47568
6 EX-32.1 alks-20170331ex3214dda8a.htm EX-32.1 21131
7 GRAPHIC alks20170331x10q001.jpg GRAPHIC 4994
8 GRAPHIC alks20170331x10q002.jpg GRAPHIC 37562
9 GRAPHIC alks20170331x10q003.jpg GRAPHIC 13438
10 GRAPHIC alks20170331x10q004.jpg GRAPHIC 96845
  Complete submission text file 0001520262-17-000020.txt   7152744

Data Files

Seq Description Document Type Size
11 EX-101.INS alks-20170331.xml EX-101.INS 1541783
12 EX-101.SCH alks-20170331.xsd EX-101.SCH 36114
13 EX-101.CAL alks-20170331_cal.xml EX-101.CAL 66976
14 EX-101.DEF alks-20170331_def.xml EX-101.DEF 107622
15 EX-101.LAB alks-20170331_lab.xml EX-101.LAB 394107
16 EX-101.PRE alks-20170331_pre.xml EX-101.PRE 255761
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 17786468
SIC: 2834 Pharmaceutical Preparations